Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: MarketLine (a Datamonitor Company)
$50.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Spire Healthcare Group PLC confirms exercises over-allotment option granted in connection with initial public offering


Friday, 15 Aug 2014 01:13pm EDT 

Spire Healthcare Group PLC:Confirms that, in connection with initial public offering of 150,100,341 ordinary shares, Morgan Stanley Securities Limited, as stabilising manager.Exercises over-allotment option granted by Fourth Cinven Fund (No. 1) Limited Partnership, Fourth Cinven Fund (No. 2) Limited Partnership, Fourth Cinven Fund (No. 3 - VCOC) Limited Partnership, Fourth Cinven Fund (No. 4) Limited Partnership.Exercises over-allotment option also granted by Fourth Cinven Fund FCPR, Fourth Cinven Fund (UBTI) Limited Partnership, Fourth Cinven Fund Co-Investment Partnership and Fourth Cinven (MACIF) Limited Partnership.As selling shareholders in respect of 14,332,711 ordinary shares in the Company (Over-allotment Shares) at offer price of 210 pence per Over-allotment Share.